TrialScientific reports2019

Long-Term Efficacy and Safety of Evocalcet in Japanese Patients with Secondary Hyperparathyroidism Receiving Hemodialysis.

Keitaro Yokoyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.